102 related articles for article (PubMed ID: 16505411)
1. Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas.
Pham D; Kris MG; Riely GJ; Sarkaria IS; McDonough T; Chuai S; Venkatraman ES; Miller VA; Ladanyi M; Pao W; Wilson RK; Singh B; Rusch VW
J Clin Oncol; 2006 Apr; 24(11):1700-4. PubMed ID: 16505411
[TBL] [Abstract][Full Text] [Related]
2. Single-cell analysis of somatic mutations in human bronchial epithelial cells in relation to aging and smoking.
Huang Z; Sun S; Lee M; Maslov AY; Shi M; Waldman S; Marsh A; Siddiqui T; Dong X; Peter Y; Sadoughi A; Shah C; Ye K; Spivack SD; Vijg J
Nat Genet; 2022 Apr; 54(4):492-498. PubMed ID: 35410377
[TBL] [Abstract][Full Text] [Related]
3. The mutagenic forces shaping the genomic landscape of lung cancer in never smokers.
Díaz-Gay M; Zhang T; Hoang PH; Khandekar A; Zhao W; Steele CD; Otlu B; Nandi SP; Vangara R; Bergstrom EN; Kazachkova M; Pich O; Swanton C; Hsiung CA; Chang IS; Wong MP; Leung KC; Sang J; McElderry J; Yang L; Nowak MA; Shi J; Rothman N; Wedge DC; Homer R; Yang SR; Lan Q; Zhu B; Chanock SJ; Alexandrov LB; Landi MT
medRxiv; 2024 May; ():. PubMed ID: 38798417
[TBL] [Abstract][Full Text] [Related]
4. Passive Smoking-Induced Mutagenesis as a Promoter of Lung Carcinogenesis.
Mochizuki A; Shiraishi K; Honda T; Higashiyama RI; Sunami K; Matsuda M; Shimada Y; Miyazaki Y; Yoshida Y; Watanabe SI; Yatabe Y; Hamamoto R; Kohno T
J Thorac Oncol; 2024 Feb; ():. PubMed ID: 38382595
[TBL] [Abstract][Full Text] [Related]
5. Screening for epidermal growth factor receptor mutations in lung cancer.
Rosell R; Moran T; Queralt C; Porta R; Cardenal F; Camps C; Majem M; Lopez-Vivanco G; Isla D; Provencio M; Insa A; Massuti B; Gonzalez-Larriba JL; Paz-Ares L; Bover I; Garcia-Campelo R; Moreno MA; Catot S; Rolfo C; Reguart N; Palmero R; Sánchez JM; Bastus R; Mayo C; Bertran-Alamillo J; Molina MA; Sanchez JJ; Taron M;
N Engl J Med; 2009 Sep; 361(10):958-67. PubMed ID: 19692684
[TBL] [Abstract][Full Text] [Related]
6. Update on epidermal growth factor receptor mutations in non-small cell lung cancer.
Riely GJ; Politi KA; Miller VA; Pao W
Clin Cancer Res; 2006 Dec; 12(24):7232-41. PubMed ID: 17189394
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer in patients who have never smoked - an emerging disease.
LoPiccolo J; Gusev A; Christiani DC; Jänne PA
Nat Rev Clin Oncol; 2024 Feb; 21(2):121-146. PubMed ID: 38195910
[TBL] [Abstract][Full Text] [Related]
8. Association between cigarette smoking history, metabolic phenotypes, and
Zhang X; Guo X; Gao Q; Zhang J; Zheng J; Zhao G; Okuda K; Tartarone A; Jiang M
J Thorac Dis; 2023 Oct; 15(10):5689-5699. PubMed ID: 37969305
[TBL] [Abstract][Full Text] [Related]
9. Common driver mutations and programmed death-ligand 1 expression in advanced non-small cell lung cancer in smokers and never smokers.
Liam CK; Yew CY; Pang YK; Wong CK; Poh ME; Tan JL; Soo CI; Loh TC; Chin KK; Munusamy V; Liam YS; Ibrahim NH
BMC Cancer; 2023 Jul; 23(1):659. PubMed ID: 37452277
[TBL] [Abstract][Full Text] [Related]
10. Association of smoking status with non-small cell lung cancer patients harboring uncommon epidermal growth factor receptor mutation.
Ko HW; Shie SS; Wang CW; Chiu CT; Wang CL; Yang TY; Chou SC; Liu CY; Kuo CS; Lin YC; Li LF; Yang CT; Wang CC
Front Immunol; 2022; 13():1011092. PubMed ID: 36341427
[TBL] [Abstract][Full Text] [Related]
11. Effects of cigarette smoking on metabolic activity of lung cancer on baseline
Jiang M; Guo X; Zhang X; Gao Q; Mei W; Zhang J; Zheng J
PeerJ; 2022; 10():e13352. PubMed ID: 35497180
[TBL] [Abstract][Full Text] [Related]
12. Association of EGFR mutations in second primary lung cancer and HER2 expression in breast cancer survivors.
Jang YJ; Kim SY; Jung HK; Kim HR; Kim CH; Lee HR; Kang HJ; Yang SH; Seol H; Na II
Transl Cancer Res; 2021 Dec; 10(12):5204-5211. PubMed ID: 35116370
[TBL] [Abstract][Full Text] [Related]
13. ALK variants, PD-L1 expression, and their association with outcomes in ALK-positive NSCLC patients.
Chang GC; Yang TY; Chen KC; Hsu KH; Huang YH; Su KY; Yu SL; Tseng JS
Sci Rep; 2020 Dec; 10(1):21063. PubMed ID: 33273548
[TBL] [Abstract][Full Text] [Related]
14.
Lettig L; Sahnane N; Pepe F; Cerutti R; Albeni C; Franzi F; Veronesi G; Ogliari F; Pastore A; Tuzi A; Pinotti G; Bovio A; Verusio C; Giordano M; Troncone G; Sessa F; Malapelle U; Furlan D
Transl Lung Cancer Res; 2019 Oct; 8(5):584-592. PubMed ID: 31737495
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of the epidermal growth factor receptor mutations in lung adenocarcinoma patients from the Middle East region.
Tfayli AH; Fakhri GB; Al Assaad MS
Ann Thorac Med; 2019; 14(3):173-178. PubMed ID: 31333766
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemistry on Sputum Samples Predicts Prognosis of Lung Cancer.
Veena VS; George PS; Rajan K; Chandramohan K; Jayasree K; Sujathan K
J Cytol; 2019; 36(1):38-43. PubMed ID: 30745738
[TBL] [Abstract][Full Text] [Related]
17. Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): an open-label, non-randomized, multicenter, phase IV clinical trial.
Markóczy Z; Sárosi V; Kudaba I; Gálffy G; Turay ÜY; Demirkazik A; Purkalne G; Somfay A; Pápai-Székely Z; Rásó E; Ostoros G
BMC Cancer; 2018 May; 18(1):598. PubMed ID: 29801465
[TBL] [Abstract][Full Text] [Related]
18. EGFR mutation, smoking, and gender in advanced lung adenocarcinoma.
Tseng CH; Chiang CJ; Tseng JS; Yang TY; Hsu KH; Chen KC; Wang CL; Chen CY; Yen SH; Tsai CM; Huang MS; Ho CC; Yu CJ; Tsai YH; Chen JS; Chou TY; Tsai MH; Chen HY; Su KY; Chen JJW; Chen HW; Yu SL; Liu TW; Chang GC
Oncotarget; 2017 Nov; 8(58):98384-98393. PubMed ID: 29228697
[TBL] [Abstract][Full Text] [Related]
19. Navigating the "No Man's Land" of TKI-Failed EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC): A Review.
Oronsky B; Ma P; Reid TR; Cabrales P; Lybeck M; Oronsky A; Oronsky N; Carter CA
Neoplasia; 2018 Jan; 20(1):92-98. PubMed ID: 29227909
[TBL] [Abstract][Full Text] [Related]
20. Prediction of EGFR and KRAS mutation in non-small cell lung cancer using quantitative
Minamimoto R; Jamali M; Gevaert O; Echegaray S; Khuong A; Hoang CD; Shrager JB; Plevritis SK; Rubin DL; Leung AN; Napel S; Quon A
Oncotarget; 2017 Aug; 8(32):52792-52801. PubMed ID: 28881771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
